MYC and B-cell non-Hodgkin lymphoma: In this model, lymphoma is driven by c-Myc oncogene overexpression controlled by an immunoglobulin heavy-chain enhancer (Eu-myc) in transgenic mice, and overexpression of the miR-17-92 cluster accelerates the development of c-Myc-induced B-cell lymphoma.